Pharma Mar, S.A. (FRA:PMRA)

Pharma Mar Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	49.73	63.24	60.02	149.81	113.35	96.21
Short-Term Investments	-	91.29	102.54	32.61	88.53	99.31
Cash & Short-Term Investments	49.73	154.53	162.56	182.42	201.88	195.52
Cash Growth	-65.56%	-4.94%	-10.89%	-9.64%	3.26%	835.71%
Accounts Receivable	33.46	34.27	27.2	29.32	50.91	24.05
Other Receivables	-	0.41	0.35	-	-	-
Receivables	33.46	34.68	27.55	29.32	50.91	24.05
Inventory	52.96	50.89	39.29	27.75	10.54	11.93
Prepaid Expenses	1.5	1.74	2.92	5.98	3.91	1
Other Current Assets	105.25	8.41	20.28	29.71	28	13.15
Total Current Assets	242.88	250.25	252.6	275.18	295.23	245.65
Property, Plant & Equipment	57	57.75	34.54	33.23	26.9	24.75
Long-Term Investments	-	2.46	6.06	49.4	10.72	20.99
Other Intangible Assets	1.21	1	1.23	1.19	1.13	0.99
Long-Term Deferred Tax Assets	38.89	36.01	31.47	30.53	27.75	33.42
Long-Term Deferred Charges	-	-	0.7	1.4	2.11	2.81
Other Long-Term Assets	1.67	2.18	13.91	2.33	4.55	1.67
Total Assets	341.66	349.64	340.52	393.26	368.39	330.26
Accounts Payable	43.8	38.81	29.17	27.49	26.93	21.04
Accrued Expenses	2.58	13.57	12.39	10.44	9.5	8.79
Short-Term Debt	-	4.72	6.46	4.48	3.84	4.77
Current Portion of Long-Term Debt	10.93	3.25	6.37	8.64	8.37	10.54
Current Portion of Leases	1.65	1.88	1.98	1.61	1.82	1.47
Current Unearned Revenue	4.99	5.38	25.93	26.11	30.89	44.71
Other Current Liabilities	24.99	15.08	13.59	18.54	4.99	3.61
Total Current Liabilities	88.93	82.69	95.89	97.32	86.35	94.92
Long-Term Debt	36.57	39.87	27.04	25.88	33.39	37.73
Long-Term Leases	1.18	1.36	1.83	2.01	1.92	2.15
Long-Term Unearned Revenue	17.27	17.17	22.14	44.9	68.63	92.56
Other Long-Term Liabilities	0.2	0.19	0.19	0.19	0.19	0.18
Total Liabilities	144.15	141.29	147.08	170.3	190.47	227.54
Common Stock	10.8	10.93	11.01	11.01	11.01	11.01
Additional Paid-In Capital	45.91	59.86	71.28	71.28	71.28	71.28
Retained Earnings	173.02	168.38	142.22	156.51	121.29	41.87
Treasury Stock	-32.24	-30.83	-31.09	-15.87	-25.68	-21.45
Comprehensive Income & Other	0.02	0.02	0.02	0.02	0.02	0.01
Total Common Equity	197.51	208.36	193.44	222.96	177.92	102.72
Shareholders' Equity	197.51	208.36	193.44	222.96	177.92	102.72
Total Liabilities & Equity	341.66	349.64	340.52	393.26	368.39	330.26
Total Debt	50.33	51.08	43.67	42.63	49.33	56.67
Net Cash (Debt)	-0.6	103.45	118.89	139.79	152.55	138.85
Net Cash Growth	-	-12.99%	-14.95%	-8.36%	9.86%	-
Net Cash Per Share	-0.03	5.89	6.64	7.74	8.44	7.58
Filing Date Shares Outstanding	17.43	17.57	17.64	18.11	18.01	18.11
Total Common Shares Outstanding	17.43	17.57	17.64	18.11	18.01	18.11
Working Capital	153.95	167.55	156.71	177.86	208.89	150.73
Book Value Per Share	11.33	11.86	10.97	12.31	9.88	5.67
Tangible Book Value	196.3	207.36	192.2	221.77	176.79	101.74
Tangible Book Value Per Share	11.26	11.80	10.90	12.25	9.82	5.62
Land	-	36.04	29.04	29.04	22.59	21.99
Machinery	-	60.68	43.28	27.87	24.32	21.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.